Related Experiment Video
Updated: Jan 28, 2026

Studying Synaptic Vesicle Pools using Photoconversion of Styryl Dyes
Published on: February 15, 2010
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
Kerstin Heurling1, Nicholas J Ashton2, Antoine Leuzy3
1Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Synaptic vesicle protein 2A (SV2A) positron emission tomography (PET) imaging shows promise for measuring synaptic density in brain disorders. This review explores SV2A PET and potential fluid biomarkers for research and clinical use.
Area of Science:
- Neuroscience
- Medical Imaging
- Biomarker Discovery
Background:
- Synaptic density is crucial for brain function and is altered in various neurological and psychiatric conditions.
- Positron emission tomography (PET) imaging targeting synaptic vesicle protein 2A (SV2A) is emerging as a tool to quantify synaptic density in vivo.
- Synaptopathies, including neurodegenerative and psychiatric diseases, represent a significant area for biomarker development.
Purpose of the Study:
- To review the current status of SV2A PET imaging as a biomarker for synaptic density.
- To explore the potential of fluid-based biomarkers for SV2A in complementing imaging data.
- To discuss future perspectives in SV2A biomarker research for neurological and psychiatric disorders.
Main Methods:
- Review of existing literature on SV2A PET imaging.
- Analysis of studies investigating fluid biomarkers related to SV2A.
- Synthesis of current research and future directions in the field.
Main Results:
- SV2A PET imaging is a rapidly developing field with significant potential for assessing synaptic density.
- Fluid-based biomarkers for SV2A are being investigated as complementary tools to PET imaging.
- The combination of imaging and fluid biomarkers may offer a more comprehensive understanding of synaptopathies.
Conclusions:
- SV2A PET imaging is a valuable tool for in vivo measurement of synaptic density.
- Fluid biomarkers targeting SV2A hold promise for clinical applications in synaptopathies.
- Further research is needed to fully establish the role and integration of these biomarkers.
Related Concept Videos
Synaptic Signaling
Synaptic Signaling
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
The Resting Membrane Potential
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Integration of Synaptic Events
Standard Electrode Potentials

